KR20030021617A - Astringent cosmetic composition - Google Patents

Astringent cosmetic composition Download PDF

Info

Publication number
KR20030021617A
KR20030021617A KR1020010054971A KR20010054971A KR20030021617A KR 20030021617 A KR20030021617 A KR 20030021617A KR 1020010054971 A KR1020010054971 A KR 1020010054971A KR 20010054971 A KR20010054971 A KR 20010054971A KR 20030021617 A KR20030021617 A KR 20030021617A
Authority
KR
South Korea
Prior art keywords
methacrylate copolymer
allyl methacrylate
ethanol
allantoin
extract
Prior art date
Application number
KR1020010054971A
Other languages
Korean (ko)
Inventor
이강태
이광식
조병기
Original Assignee
주식회사 코리아나화장품
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 코리아나화장품 filed Critical 주식회사 코리아나화장품
Priority to KR1020010054971A priority Critical patent/KR20030021617A/en
Publication of KR20030021617A publication Critical patent/KR20030021617A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/26—Aluminium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Abstract

PURPOSE: An astringent composition containing allantoin chloro hydroxy aluminium as a mixture of chlorohydroxy aluminium and allantoin and a Galla Rhois extract is provided which has an excellent astringent effect and stability and high usability as a cosmetic for administration of a skin pore. CONSTITUTION: Allantoin chloro hydroxy aluminium and a Galla Rhois extract are dissolved in ethanol and mixed with an allyl methacrylate copolymer, followed by removing ethanol with a vacuum concentrator to produce an allyl methacrylate copolymer containing the allantoin chloro hydroxy aluminium and Galla Rhois extract. The astringent cosmetic composition contains 0.5 to 5.0%(w/w) of the produced copolymer, based on the total weight of the composition. The Galla Rhois extract is obtained by extracting 70% ethanol for 4hr.

Description

수렴 화장료 조성물{Astringent cosmetic composition}Astringent cosmetic composition

본 발명은 피부의 수렴효과를 극대화 시킨 수렴 화장료 조성물에 관한 것이다.The present invention relates to a convergent cosmetic composition to maximize the astringent effect of the skin.

일반적으로 우리 피부는 외부의 유해 환경(자외선, 대기 오염), 스트레스등에 의해 다양한 피부 트러블을 일으키게 된다. 그 중 여성들에게 가장 큰 관심의 하나가 모공과 관련된 피부의 변화이다. 모공은 말 그대로 털이 나오는 구멍으로 해부학적으로 보면 모공으로 털이 나오고 털 뿌리인 모근의 모낭쪽으로 피지선이라는 기름샘이 있어 피지가 분비되어 나오는 통로이다. 모공은 사춘기 이후 피지분비가 왕성해지면서 넓어지거나 모공속 노폐물, 피지등에 의해 염증이 일어나 장기간 축적되어 모공이 넓어진다. 또한 개인차가 있긴 하지만 20대 중반부터 피부노화가 시작되어 모공벽을 지지하고 있는 콜라겐 섬유와 탄력섬유가 변성 피부탄력이 없어져 모공이 처지게 보일 수도 있다. 따라서 이러한 모공의 변화를 최소화하기 위하여 화장품에서는 다양한 방법을 통해 모공확대를 억제하고자 노력한다.In general, our skin causes various skin problems due to external harmful environment (ultraviolet rays, air pollution) and stress. One of the biggest concerns among women is the skin changes associated with pores. The pores are literally holes of hairs, which are anatomically seen as hairs coming out of the pores and oil glands called sebaceous glands toward the hair follicles of the hair roots. After puberty, the sebum secretion becomes vigorous and widened, or the pores become inflamed by waste products and sebum, which accumulate for a long time, and the pores widen. In addition, although there are individual differences, skin aging begins in the mid-20s, and the collagen fibers and elastic fibers supporting the pores wall may lose their deformed skin elasticity and cause the pores to sag. Therefore, in order to minimize the change of pores, cosmetics try to suppress pore enlargement through various methods.

피부를 수축하는 작용으로는 물리적 작용과 화학적 작용이 있다. 물리적 작용은 화장수에 함유된 알콜이 증발될 때 생기는 증발열에 의해 피부의 표면온도를 일시적으로 저하시킴으로써 모공을 수축시켜주어 효과를 주고, 화학적 작용은 유기산 또는 단백질의 응고 효과를 가진 물질에 의해 피지선 분비구의 단백질을 응고, 수축하여 수렴효과를 준다.Contraction of the skin is a physical and chemical action. The physical action is to reduce the surface temperature of the skin temporarily by the heat of evaporation when the alcohol contained in the lotion evaporates, thereby contracting the pores, and the chemical action is secreted by sebaceous glands by substances having a coagulation effect of organic acids or proteins. Coagulation and contraction of the protein of the sphere gives a convergent effect.

수렴제를 피부에 도포 하였을 때, 피부에서의 효과는 국소적이다. 수렴제에 의한 효과는 머리카락의 직립, 팽팽한 피부(최소한 피부가 팽팽하게 됨을 느낌), 일시적인 모공 또는 땀구멍의 수축, 발한작용의 억제, 지성피부의 완화, 상처부위의 혈액 응고, 상처 치유 및 조직성장의 촉진 등이 있다. 이러한 많은 장점으로 수렴효과를 갖는 물질은 화장품에서 중요한 성분으로 인정되고 있다.When astringents are applied to the skin, the effect on the skin is local. The effect of astringents is on the straightening of the hair, on tight skin (at least the skin feels tight), temporary contraction of pores or pores, inhibition of sweating, relief of oily skin, blood coagulation of wounds, wound healing and tissue growth Promotion. Due to these many advantages, a substance having a convergence effect is recognized as an important ingredient in cosmetics.

수렴제는 크게 양이온성 수렴제와 음이온성 수렴제로 나뉘는데, 양이온성 수렴제로는 알란토인 하이드록시 알루미늄, 염화납, 염화 알루미늄, 염화 제이철, 산화 아연, 유산알루미늄등이 있고, 음이온성 수렴제로는 구연산, 주석산, 탄닌산, 젖산, 사과산등이 있다.Astringents are largely divided into cationic and anionic ones. Cationic ones include allantoin hydroxyaluminum, lead chloride, aluminum chloride, ferric chloride, zinc oxide, aluminum lactate, and anionic ones include citric acid, tartaric acid, Tannic acid, lactic acid, and malic acid.

화학적으로 수렴효과를 나타내는 수렴제는 두 그룹으로 분류되는데, 첫째 유기산 또는 무기산의 금속염으로 수렴효과를 주는 금속이온으로는 철, 크롬, 알루미늄, 아연, 납, 수은, 주석, 구리, 은, 지르코늄등이 있으며 이들은 한선의 활동을 저하시킴으로써 수렴효과를 나타낸다. 금속염에 의한 수렴효과는 금속의 종류, 염화합물에서의 음이온의 종류에 따라 다르고, 그 효과 또한 높지 않다. 둘째 저 분자량의 유기산으로 구연산과 젖산이 가장 보편적으로 사용되고 있다. 셋째 저급 알코올이 있다. 이런 수렴제들은 일반적으로 단백질을 침전시키는 효과를 가지고 있어 피부를 수축시켜 수렴효과를 준다.Chemically astringent astringents are classified into two groups. First, metal ions that converge with metal salts of organic or inorganic acids include iron, chromium, aluminum, zinc, lead, mercury, tin, copper, silver, and zirconium. They have a convergent effect by degrading Hanseon's activity. The convergence effect by the metal salt is different depending on the kind of metal and the kind of anion in the salt compound, and the effect is also not high. Second, citric acid and lactic acid are the most commonly used low molecular weight organic acids. Third is lower alcohol. These astringents generally have the effect of precipitating proteins, causing the skin to shrink and give astringent effect.

최근에는 자연성 화장품의 추세에 맞춰 수렴효과를 가지고 있는 식물 추출물들이 수렴제로 개발되고 있는데, 이들 식물 추출물의 대부분은 탄닌(Tannin)을 함유하고 있는 것이 특징이다.Recently, plant extracts having astringent effects have been developed as astringents in accordance with the trend of natural cosmetics. Most of these plant extracts are characterized by containing tannin.

본 발명은 알루미늄 클로로하이드록시와 알란토인을 결합시켜 에탄올에 용해되기 쉽게 만들고, 이것을 오배자 추출물과 에탄올에 녹인 후, 수용성 및 고형성분을 포집하여 안정화시켜주는 알릴 메타크릴레이트 코폴리머에 포집시켜 화장료에 적용함으로써 과도하게 열려진 모공이나 땀구멍을 수축시켜 피부에 탄력감과 유연감을 느낄 수 있게 하는 피부의 수렴효과가 극대화된 화장료를 제공하는 것을 목적으로 한다.The present invention makes it easy to dissolve in ethanol by combining aluminum chlorohydroxy and allantoin, and then dissolved in the gall extract and ethanol, and then collected in an allyl methacrylate copolymer that collects and stabilizes the water-soluble and solid components to be applied to cosmetics. The purpose of the present invention is to provide a cosmetic that maximizes the astringent effect of the skin, which makes the skin feel elasticity and suppleness by contracting excessively opened pores or pores.

본 발명은 알루미늄 클로로하이드록시와 알란토인을 결합한 것과 오배자 추출물의 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 포함 포함함으로써 수렴효과가 극대화되는 수렴 화장료에 관한 것이다.The present invention relates to a convergent cosmetic that maximizes the convergence effect by including an allyl methacrylate copolymer in which aluminum chlorohydroxy and allantoin are combined and water soluble and solid components of the gall extract.

본 발명의 수렴 화장료는 알루미늄 클로로하이드록시와 알란토인을 결합한 것과 오배자 추출물의 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 화장료 총 중량에 대하여 0.5~5.0%(w/w) 함유하는 것이 바람직하다.The astringent cosmetic of the present invention preferably contains 0.5 to 5.0% (w / w) of allyl methacrylate copolymer, in which aluminum chlorohydroxy and allantoin are combined, and the water-soluble and solid components of the gall extract are collected. Do.

또한 상기의 알릴 메타크릴레이트 코 폴리머에 포집되는 알루미늄 클로로하이드록시와 알란토인이 결합된 것과 오배자 추출물은 알릴 메타크릴레이트 코 폴리머의 중량에 대하여 각각 1~20%(w/w)로 함유되는 것이 바람직하다.In addition, the combination of aluminum chlorohydroxy and allantoin trapped in the allyl methacrylate copolymer and the gall extract are preferably contained 1 to 20% (w / w) based on the weight of the allyl methacrylate copolymer. Do.

상기의 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머는 알루미늄 클로로하이드록시와 알란토인(Allantoin)을 결합시켜 에탄올에 용해되기 쉽게 만든 것과 오배자 추출물을 에탄올에 녹이고, 두 개의 성분이 들어있는 에탄올을 알릴 메타크릴레이트 코폴리머에 섞은 후, 에탄올을 제거하는 것에 의해 제조할 수 있다.The allyl methacrylate copolymer, in which the water-soluble and solid components are collected, is made by combining aluminum chlorohydroxy and allantoin, making it easy to dissolve in ethanol, and dissolving the gall bladder extract in ethanol and ethanol containing two components. It can be prepared by mixing in the allyl methacrylate copolymer and then removing the ethanol.

상기의 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 제조 과정에서 에탄올은 진공감압농축기를 이용하여 제거하는 것이 바람직하다.In preparing the allyl methacrylate copolymer in which the water-soluble and solid components are collected, ethanol is preferably removed by using a vacuum concentrator.

본 발명에서는 알루미늄 클로로하이드록시와 알란토인(Allantoin)을 결합시켜 에탄올에 용해되기 쉽게 만든 것으로 ALCLOXA AS MODIFIED(제조사 : AKEMA S.r.l., 이탈리아)를 사용하며, 이 물질은 여드름 치료에 효과적이며 수렴 효과, 항균, 각질박리 효과작용이 있으며 pH 5에서 6.5범위에서 안정적이다. 피부에 적용되면 알루미늄분자는 피부 단백질과 작용하여 수렴효과를 주며 동시에 알란토인은 피부 안정(soothing), 각질박리효과를 나타낸다.In the present invention, it is easy to dissolve in ethanol by combining aluminum chlorohydroxy and allantoin, and ALCLOXA AS MODIFIED (manufacturer: AKEMA Srl, Italy) is used to treat acne, which has an effective astringent effect, antibacterial effect, It has an exfoliating effect and is stable in the range of pH 5 to 6.5. When applied to the skin, aluminum molecules interact with skin proteins to give a convergent effect, while allantoin has a skin soothing and exfoliating effect.

오배자 추출물은 70%의 에탄올에서 4시간 끓여 추출한 후 농축한 것을 사용하였다. 오배자 추출물은 탄닌을 많이 함유한 물질로 단백질 응집효과가 매우 뛰어나 피부에 도포 되면 피부단백질과의 결합을 통해 피부에 수렴효과를 줄 수 있다.The gall extract was boiled in 70% ethanol for 4 hours and extracted and concentrated. Gallja extract is a substance that contains a lot of tannins and has a very good protein aggregation effect. When applied to the skin, it can be combined with skin proteins to give a convergent effect on the skin.

수용성 및 고형성분을 포집하여 안정화시켜주는 알릴 메타크릴레이트 코폴리머로서는 Poly-PoreTM(제조사 : CHEMDAL CORPORATION, 미국)를 사용하였다.Poly-Pore TM (manufactured by CHEMDAL CORPORATION, USA) was used as the allyl methacrylate copolymer that collects and stabilizes water-soluble and solid components.

본 발명은 알루미늄 클로로하이드록시와 알란토인이 결합된 것과 오배자 추출물의 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 포함함으로써 원료의 안정성과 함께 피부에 3단계의 수렴효과를 제공한다.The present invention includes allyl methacrylate copolymer in which aluminum chlorohydroxy and allantoin are combined and water soluble and solid components of the gall extract, thereby providing a three-step convergence effect on the skin with stability of the raw materials.

먼저 본 원료를 피부에 도포함으로써 에탄올에 의한 물리적인 수렴 효과가 있으며, 다음으로 알란토인과 오배자 등이 피부 단백질과의 반응함으로써 수렴효과를 준다. 마지막으로는 알릴 메타크릴레이트 코폴리머(Poly-PoreTM) 자체적으로 피지 흡착 효과가 있으므로 피지 조절을 통해 피부의 수렴효과를 제공한다.First, the raw material is applied to the skin to have a physical astringent effect by ethanol, and then allantoin and gall bladder give a convergence effect by reacting with skin protein. Finally, allyl methacrylate copolymer (Poly-Pore TM ) itself has sebum adsorption effect, so it provides astringent effect of skin through sebum control.

본 발명에 따라 포집된 알릴 메타크릴레이트 코폴리머는 통상적인 기초 화장료, 예를 들면, 유연화장수(스킨), 영양화장수(밀크로션), 영양크림, 맛사지크림, 엣센스, 팩 등의 제형에 사용될 수 있다.The allyl methacrylate copolymer collected according to the present invention can be used in the formulation of conventional basic cosmetics, such as softener (skin), nutritious (milk lotion), nourishing cream, massage cream, essence, pack, etc. have.

이하에서 실시예 및 실험예를 통하여 본 발명을 더욱 상세히 설명하나 이에 의하여 본 발명이 제한 되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples and Experimental Examples, but the present invention is not limited thereto.

실시예 1. 오배자 추출물의 추출Example 1 Extraction of Mellitus Extract

오배자를 정제수로 세척하고 건조시킨 다음 분말화한 오배자 가루 200g을70% 에탄올 용액 2.5L에 넣고, 냉각콘덴서가 달린 환류추출기에서 4시간 끓여 추출한 다음, 300 메쉬 여과포로 여과하고, 잔사를 같은 방법으로 1회 더 추출하였다. 각각의 추출액을 합하여 와트만 5번 여과지로 여과 후 감압 농축기를 이용하여 용매를 제거한 후, 동결건조하여 건조 중량 61.4g을 얻었다.The gallola was washed with purified water and dried, and then 200 g of powdered gallola flour was added to 2.5 L of a 70% ethanol solution, boiled for 4 hours in a reflux extractor with a cooling condenser, filtered through a 300 mesh filter cloth, and the residue was filtered in the same manner. One more extraction. Each extract was combined, filtered through Whatman No. 5 filter paper, and the solvent was removed using a vacuum concentrator, and then lyophilized to obtain a dry weight of 61.4 g.

실시예 2. ALCLOA AS MODIFIED와 오배자 추출물을 Poly-PoreExample 2 Poly-Pore with ALCLOA AS MODIFIED TMTM 에 포집시키는 방법How to capture to

ALCLOXA AS MODIFIED와 오배자 추출물을 먼저 에탄올에 녹인다. 그런 다음 두 개의 성분이 들어있는 에탄올을 Poly-PoreTM에 펼친 후 부드럽게 섞는다. 이후 진공감압 농축기를 이용하여 30℃에서 감압농축하여 에탄올을 제거하고 최종적으로 ALCLOXA AS MODIFIED와 오배자 추출물을 Poly-PoreTM에 포집시킨다.ALCLOXA AS MODIFIED and the gall bladder extract are first dissolved in ethanol. Then spread the ethanol containing the two components in Poly-Pore TM and mix gently. Thereafter, the mixture was concentrated under reduced pressure at 30 ° C. using a vacuum depressurizer to remove ethanol, and finally, ALCLOXA AS MODIFIED and the Gallja extract were collected in Poly-Pore ™ .

실험예 1. ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 Poly-PoreExperimental Example 1. Poly-Pore with ALCLOXA AS MODIFIED TMTM 의 단백질 응집 효과 비교Protein aggregation effect

ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 Poly-PoreTM의 단백질 응집효과를 다음과 같은 방법으로 측정하였다. 먼저 단백질은 알부민이 함유된 50mM 구연산 완충용액(pH 4.5)에 위 원료1g을 넣고 잘 흔들어 준 다음 5분 정치시킨 뒤 650nM에서 탁도를 측정하였다. 이때 대조군으로 오배자 추출물과 알란토인 화합물을 사용하였다. 아래의 표 1에서 Poly-PoreTM은 Poly-PoreTM에 ALCLOXA AS MODIFIED와 오배자 추출물을 포집한 것을 말한다.Protein agglutination effect of ALCLOXA AS MODIFIED and Poly-Pore TM collected from the gall bladder extract was measured by the following method. First, the protein was added to 1 g of the above raw material in 50 mM citric acid buffer solution (pH 4.5) containing albumin, and then shaken well. After standing for 5 minutes, the turbidity was measured at 650 nM. At this time, as a control, the gall bladder extract and allantoin compound were used. In Table 1 below, Poly-Pore ™ refers to the collection of ALCLOXA AS MODIFIED and Gallnut Extract in Poly-Pore ™ .

각 원료의 단백질 응집효과 비교Comparison of Protein Aggregation Effects of Each Raw Material 구분division 단백질 응집효과Protein aggregation effect 알부민의 농도Albumin concentration 0.067 mg/ml0.067 mg / ml 0.335 mg/ml0.335 mg / ml Poly-PoreTM Poly-Pore TM 0.5950.595 1.2351.235 알란토인 화합물Allantoin compound 0.2360.236 0.7580.758 오배자 추출물Gallnut extract 0.3590.359 0.9480.948

상기의 표에서 시료들의 수치는 650nM에서 측정된 탁도를 나타내며 탁도가 높을 수록 단백질 응집효과가 뛰어난 것으로 본다. 따라서 Poly-PoreTM의 단백질 응집효과가 다른 시료들에 비하여 월등함을 확인할 수 있다.The numerical values of the samples in the above table indicate turbidity measured at 650 nM, and the higher the turbidity, the better the protein aggregation effect. Therefore, it can be confirmed that the protein aggregation effect of Poly-Pore TM is superior to other samples.

처방예 1.Prescription Example 1.

실시예 2에서 제조한 ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 Poly-PoreTM을 함유한 유연 화장수(스킨로션)의 처방예는 다음과 같다(표에서 Poly-PoreTM은 Poly-PoreTM에 ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 것을 말한다).Example 2 A formulation of ALCLOXA flexible lotion (skin lotion) containing AS MODIFIED and nut gall extract is collected Poly-Pore TM manufactured are as follows (Table Poly-Pore TM is ALCLOXA the Poly-Pore TM AS MODIFIED and gallant extracts are collected).

배합성분Ingredient 중량(%)weight(%) Poly-PoreTM Poly-Pore TM 1.01.0 1,3 부틸렌 글리콜1,3 butylene glycol 6.06.0 글리세린glycerin 4.04.0 올레일 알코올Oleyl alcohol 0.10.1 폴리솔베이트 20Polysorbate 20 0.50.5 에탄올ethanol 15.015.0 벤조페논-9Benzophenone-9 0.050.05 향incense 0.020.02 방부제antiseptic 0.020.02 정제수Purified water 잔량Remaining amount 계system 100100

처방예 2.Prescription Example 2.

실시예 2에서 제조한 ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 Poly-PoreTM을 함유한 영양화장수(밀크 로션)의 처방예는 다음과 같다(표에서 Poly-PoreTM은 Poly-PoreTM에 ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 것을 말한다).Example 2 Preparation Example of ALCLOXA AS MODIFIED and gallnut the extract containing the collected Poly-Pore TM Nutritional toilet water (milk lotion) manufactured are as follows (Table Poly-Pore TM is ALCLOXA the Poly-Pore TM AS MODIFIED and gallant extracts are collected).

배합성분Ingredient 중량(%)weight(%) Poly-PoreTM Poly-Pore TM 2.02.0 프로필렌 글리콜Propylene glycol 6.06.0 글리세린glycerin 4.04.0 트리에탄올아민Triethanolamine 1.21.2 토코페릴아세테이트Tocopheryl Acetate 3.03.0 유동파라핀Liquid paraffin 5.05.0 스쿠알란Squalane 3.03.0 마카다미아너트오일Macadamia Nut Oil 2.02.0 폴리솔베이트 60Polysorbate 60 1.51.5 솔비탄세스퀴올레이트Sorbitan sesquioleate 1.01.0 카르복시비닐폴리머Carboxy Vinyl Polymer 1.01.0 향incense 0.020.02 방부제antiseptic 0.020.02 정제수Purified water 잔량Remaining amount 계system 100100

처방예 3.Prescription Example 3.

실시예 2에서 제조한 ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 Poly-PoreTM을 함유한 영양크림의 처방예는 다음과 같다(표에서 Poly-PoreTM은 Poly-PoreTM에 ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 것을 말한다).Example 2 ALCLOXA formulation of nutrition cream containing AS MODIFIED and the nut gall extract is collected Poly-Pore TM manufactured are as follows (Table Poly-Pore TM is ALCLOXA AS MODIFIED and nut gall extract the Poly-Pore TM Says it was collected).

배합성분Ingredient 중량(%)weight(%) Poly-PoreTM Poly-Pore TM 3.03.0 바세린Vaseline 7.07.0 유동파라핀Liquid paraffin 10.010.0 밀납Beeswax 2.02.0 폴리솔베이트 60Polysorbate 60 2.02.0 솔비탄세스퀴올레이트Sorbitan sesquioleate 2.52.5 스쿠알란Squalane 3.03.0 프로필렌글리콜Propylene glycol 6.06.0 글리세린glycerin 4.04.0 트리에탄올아민Triethanolamine 0.50.5 카르복시비닐폴리머Carboxy Vinyl Polymer 0.50.5 토코페롤아세테이트Tocopherol Acetate 0.10.1 향incense 0.020.02 방부제antiseptic 0.020.02 정제수Purified water 잔량Remaining amount 계system 100100

실험예 2.Experimental Example 2.

처방예 3 에서 제조한 크림에 의한 피부 표면 변화를 3차원 화상분석기로 분석하여 수렴 효과를 측정하였다. 즉, 팔의 하박에 사용전과 사용 후 10분, 20분에서의 피부 상태 변화를 실리콘 재질을 이용하여 레플리카를 뜬 후 3차원 화상 분석기로 이미지를 분석하여 주름수, 주름의 변화, 높이, 펴짐, 간격을 측정하였다. 본 제형과의 비교를 위해 오배자 추출물과 알란토인이 개별적으로 함유된 크림을 제조하여 각각 비교예 1, 2로 사용하였다. 비교예 1 과 2는 각각 처방예 3에서 ALCLOXA AS MODIFIED와 오배자 추출물이 포집된 Poly-PoreTM를 대체하여 오배자 추출물, ALCLOXA AS MODIFIED를 첨가하여 만든 크림이다.The skin surface change by the cream prepared in Formulation Example 3 was analyzed by a three-dimensional image analyzer to measure the convergence effect. In other words, before and after use, the skin condition changes at 10 minutes and 20 minutes before and after use were made using a silicone material, and the images were analyzed with a three-dimensional image analyzer to determine the number of wrinkles, changes in wrinkles, height, and spread, The interval was measured. For comparison with the present formulations, a cream containing separately five gallza extract and allantoin was prepared and used as Comparative Examples 1 and 2, respectively. Comparative Examples 1 and 2 are the creams prepared by adding the Algalox extract and ALCLOXA AS MODIFIED to replace Poly-Pore TM in which ALCLOXA AS MODIFIED and the Algal Extract were collected in Formulation Example 3, respectively.

각 제품을 단기간 적용에 의한 피부 표면 변화Changes in skin surface due to short term application of each product 구분division 주름수Wrinkles 주름높이(mm)Corrugation Height (mm) 주름의 퍼짐(mm)Wrinkle spread (mm) 주름의 간격(mm)Wrinkle thickness (mm) 사용전Before use 10분10 minutes 20분20 minutes 사용전Before use 10분10 minutes 20분20 minutes 사용전Before use 10분10 minutes 20분20 minutes 사용전Before use 10분10 minutes 20분20 minutes 처방예 3의 크림Cream of Prescription Example 3 0.000.00 18.218.2 25.6825.68 0.000.00 -18.86-18.86 -27.9-27.9 0.000.00 -4.94-4.94 -6.85-6.85 0.000.00 -17.86-17.86 -23.5-23.5 비교예 1(오배자 추출물)Comparative Example 1 (Gallander Extract) 0.000.00 15.415.4 21.7821.78 0.000.00 -17.78-17.78 -25.35-25.35 0.000.00 -4.04-4.04 -5.68-5.68 0.000.00 -13.25-13.25 -19.42-19.42 비교예 2(알란토인)Comparative Example 2 (Allantoin) 0.000.00 10.1210.12 12.6312.63 0.000.00 -9.19-9.19 -14.56-14.56 0.000.00 -2.80-2.80 -3.78-3.78 0.000.00 -8.45-8.45 -12.32-12.32

수렴효과가 우수할수록 주름수, 주름의 높이, 주름의 펴짐, 주름의 간격등 단기간 적용에 의한 피부 표면 변화는 다음과 같다.The better the astringent effect, the more the skin surface changes due to short-term application such as the number of wrinkles, the height of wrinkles, the unfolding of wrinkles, and the interval of wrinkles are as follows.

단시간 적용에 의한 수렴효과가 우수할수록 주름수는 증가하고, 주름의 높이, 주름의 펴짐, 주름의 간격은 감소한다.As the convergence effect of the short time application is excellent, the number of wrinkles increases, and the height of wrinkles, unfolding of wrinkles, and spacing of wrinkles decrease.

표 2에서보는 바와 같이 처방예 3에서 제조한 크림은 오배자추출물, 알란토인을 첨가하여 제조한 비교예 1, 2의 크림에 비해 우수한 수렴효과가 있음을 확인할 수 있다.As shown in Table 2, it can be confirmed that the cream prepared in Formulation Example 3 has an excellent astringent effect compared to the creams of Comparative Examples 1 and 2 prepared by adding the gall bladder extract and allantoin.

상기 실험예에서 알 수 있는 바와 같이 알루미늄 클로로하이드록시와 알란토인을 결합시켜 에탄올에 용해되기 쉽게 만든 것과 오배자 추출물을 에탄올에 녹인 후, 수용성 및 고형성분을 포집하여 안정화시켜주는 알릴 메타크릴레이트 코폴리머에 포집시킨 것을 포함하는 수렴 화장료는 수렴 효과가 우수하며 안정성이 뛰어나 피부 모공관리 화장료로서의 이용가능성이 매우 높다.As can be seen in the above experimental example, aluminum chlorohydroxy and allantoin are easily dissolved in ethanol, and the quinine extract is dissolved in ethanol, and then allyl methacrylate copolymer which collects and stabilizes water-soluble and solid components. Converging cosmetics including the collected is excellent in the convergence effect and excellent in stability as a skin pores care cosmetics.

Claims (7)

알루미늄 클로로하이드록시와 알란토인을 결합한 것과 오배자 추출물의 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 포함하는 것을 특징으로하는 수렴 화장료.An astringent cosmetic comprising an allyl methacrylate copolymer in which aluminum chlorohydroxy and allantoin are combined, and water soluble and solid components of the gall extract are collected. 제1항에 있어서, 알루미늄 클로로하이드록시와 알란토인을 결합한 것과 오배자 추출물의 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 화장료 총 중량에 대하여 0.5~5.0%(w/w) 포함하는 것을 특징으로 하는 수렴 화장료.The method of claim 1, wherein the allyl methacrylate copolymer, which combines aluminum chlorohydroxy and allantoin, and the water-soluble and solid components of the gall extract, contains 0.5 to 5.0% (w / w) based on the total weight of the cosmetic. Convergence cosmetics made with. 제2항에 있어서, 알릴 메타크릴레이트 코 폴리머에 포집되는 알루미늄 클로로하이드록시와 알란토인이 결합된 것과 오배자 추출물이 알릴 메타크릴레이트 코 폴리머의 중량에 대하여 각각 1~20%(w/w)로 포함되는 것을 특징으로 하는 수렴 화장료.3. The method of claim 2, wherein the combination of aluminum chlorohydroxy and allantoin trapped in the allyl methacrylate copolymer, and the gall bladder extract is 1 to 20% (w / w), respectively, based on the weight of the allyl methacrylate copolymer. Convergence cosmetics, characterized in that. 알루미늄 클로로하이드록시와 알란토인(Allantoin)을 결합시켜 에탄올에 용해되기 쉽게 만든 것과 오배자 추출물을 에탄올에 녹이고, 두 개의 성분이 들어있는 에탄올을 알릴 메타크릴레이트 코폴리머에 섞은 후, 에탄올을 제거하는 것에 의해 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 제조하는 방법.Made by combining aluminum chlorohydroxy and allantoin to make it easier to dissolve in ethanol, and dissolving the gall bladder extract in ethanol, mixing ethanol containing two components with allyl methacrylate copolymer, and then removing ethanol. A process for preparing allyl methacrylate copolymer in which water-soluble and solid components are collected. 제4항에 있어서, 에탄올을 진공감압농축기를 이용하여 제거하는 것을 특징으로하는 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머를 제조하는 방법.5. The method of claim 4, wherein the ethanol is removed using a vacuum concentrator, wherein the water-soluble and solid component-packed allyl methacrylate copolymer is prepared. 제1항에 있어서, 오배자 추출물이 70% 에탄올에서 4시간 끓여 추출한 후 농축한 것임을 특징으로하는 수렴 화장료.The astringent cosmetic composition according to claim 1, wherein the five gall extract is concentrated after boiling for 4 hours in 70% ethanol. 제1항에 있어서, 수용성 및 고형성분이 포집된 알릴 메타크릴레이트 코폴리머가 유연화장수(스킨), 영양화장수(밀크로션), 영양크림, 맛사지크림, 엣센스, 팩 중에서 선택된 기초 화장료에 사용되는 것을 특징으로 하는 수렴 화장료.The method of claim 1, wherein the allyl methacrylate copolymer is a water-soluble and solid components collected is used in the base cosmetic selected from softening water (skin), nutrient cream (milk lotion), nutrition cream, massage cream, essence, pack Convergence cosmetics characterized by.
KR1020010054971A 2001-09-07 2001-09-07 Astringent cosmetic composition KR20030021617A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020010054971A KR20030021617A (en) 2001-09-07 2001-09-07 Astringent cosmetic composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020010054971A KR20030021617A (en) 2001-09-07 2001-09-07 Astringent cosmetic composition

Publications (1)

Publication Number Publication Date
KR20030021617A true KR20030021617A (en) 2003-03-15

Family

ID=27722937

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020010054971A KR20030021617A (en) 2001-09-07 2001-09-07 Astringent cosmetic composition

Country Status (1)

Country Link
KR (1) KR20030021617A (en)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6210006A (en) * 1985-07-05 1987-01-19 Shiseido Co Ltd Skin cosmetic
US4673571A (en) * 1983-07-25 1987-06-16 Societe Anonyme Dite: L'oreal Cosmetic compositions for hair and skin which contain a methacrylic or acrylic acid copolymer, an alkyl acrylate and/or methacrylate and an allyl derivative
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
JPH0436216A (en) * 1990-05-29 1992-02-06 Sunstar Inc Cosmetic
KR940006066A (en) * 1992-07-22 1994-03-23 완다 케이. 덴슨-로우 Transponder Detection and Tracking System
JPH09291022A (en) * 1996-04-25 1997-11-11 Sunstar Inc Skin astringent cosmetic
JP2000212022A (en) * 1999-01-18 2000-08-02 Nikko Chemical Co Ltd Cosmetic
KR100330703B1 (en) * 1998-10-17 2002-06-20 서경배 Cosmetic pigments and preparation method thereof

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4863725A (en) * 1982-10-27 1989-09-05 Deckner George E Novel clear oil-free moisturizer composition
US4673571A (en) * 1983-07-25 1987-06-16 Societe Anonyme Dite: L'oreal Cosmetic compositions for hair and skin which contain a methacrylic or acrylic acid copolymer, an alkyl acrylate and/or methacrylate and an allyl derivative
JPS6210006A (en) * 1985-07-05 1987-01-19 Shiseido Co Ltd Skin cosmetic
JPH0436216A (en) * 1990-05-29 1992-02-06 Sunstar Inc Cosmetic
KR940006066A (en) * 1992-07-22 1994-03-23 완다 케이. 덴슨-로우 Transponder Detection and Tracking System
JPH09291022A (en) * 1996-04-25 1997-11-11 Sunstar Inc Skin astringent cosmetic
KR100330703B1 (en) * 1998-10-17 2002-06-20 서경배 Cosmetic pigments and preparation method thereof
JP2000212022A (en) * 1999-01-18 2000-08-02 Nikko Chemical Co Ltd Cosmetic

Similar Documents

Publication Publication Date Title
JP4589483B2 (en) Acne preventive and therapeutic agent
KR101064904B1 (en) Cosmetic composition for improving acne comprising natural extracts
CN108294973B (en) Whitening skin cream
CN109350591B (en) Dry facial mask for beautifying face and preparation method thereof
KR20200113600A (en) Composition for hairloss and scalp care
US6183747B1 (en) Use of plant Momordica charactia extracts for treatment of acne acid
KR20020043339A (en) Cosmetics compositions having a plum extract
CN108653084B (en) Growth factor-containing skin care composition for men and application thereof
KR940001125B1 (en) Thirosinase interfering drug composition containing chrysanthemum moriflium ramat extracts
KR100376136B1 (en) Astringent Cosmetic Composition Containing Yulpi Extract
KR20090105222A (en) The cosmetic composition for the reduction of skin pores
CN108938514A (en) A kind of clear skin acne-removing liquid of quantum and preparation method thereof
KR20030021617A (en) Astringent cosmetic composition
KR102027349B1 (en) Composition of skin external application containing polysaccharides, and the method for preparing thereof
JPS5913709A (en) Moisturizer
KR20130062484A (en) External composition for skin containing humulus japonicas sieboid and zucc. extract
CN112933006A (en) Facial cleanser containing composition for regulating time rhythm and preparation method thereof
KR100829717B1 (en) Astringent Cosmetic Composition Comprising the Extract from the Fruit of Poncirus trifoliata as Active Ingredient
KR100829720B1 (en) Astringent Cosmetic Composition Comprising the Extract from the Fruit of Rubus coreanum as Active Ingredient
KR100946584B1 (en) Cosmetic Composition Comprising Poncirus trifoliata fruit extract and Nymphaea caerulea extract
JP2006160629A (en) Collagen production accelerator and external preparation for skin containing the same
KR20200104999A (en) Cosmetic Compositions for Anti-aging Comprising Extracts of Plants
CN107550810A (en) A kind of Chinese medicine composition and its preparation method and application
JP3754025B2 (en) Cell activator, antioxidant, and skin external preparation
KR102337422B1 (en) Cosmetic composition comprising jojoba oil for skin calming care and skin trouble improvement, and preparing method the same

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application